These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 24672028)

  • 21. Acetylation changes at lysine 5 of histone H4 associated with lytic gene promoters during reactivation of Kaposi's sarcoma-associated herpesvirus.
    Hwang LR; Cha S; Jong JE; Jang JH; Seo T
    Acta Virol; 2014; 58(3):282-6. PubMed ID: 25283865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. X box binding protein XBP-1s transactivates the Kaposi's sarcoma-associated herpesvirus (KSHV) ORF50 promoter, linking plasma cell differentiation to KSHV reactivation from latency.
    Wilson SJ; Tsao EH; Webb BL; Ye H; Dalton-Griffin L; Tsantoulas C; Gale CV; Du MQ; Whitehouse A; Kellam P
    J Virol; 2007 Dec; 81(24):13578-86. PubMed ID: 17928342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. beta-Adrenoreceptors reactivate Kaposi's sarcoma-associated herpesvirus lytic replication via PKA-dependent control of viral RTA.
    Chang M; Brown HJ; Collado-Hidalgo A; Arevalo JM; Galic Z; Symensma TL; Tanaka L; Deng H; Zack JA; Sun R; Cole SW
    J Virol; 2005 Nov; 79(21):13538-47. PubMed ID: 16227274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression.
    Krishnan HH; Naranatt PP; Smith MS; Zeng L; Bloomer C; Chandran B
    J Virol; 2004 Apr; 78(7):3601-20. PubMed ID: 15016882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic analysis of KSHV latent and lytic genomes.
    Toth Z; Maglinte DT; Lee SH; Lee HR; Wong LY; Brulois KF; Lee S; Buckley JD; Laird PW; Marquez VE; Jung JU
    PLoS Pathog; 2010 Jul; 6(7):e1001013. PubMed ID: 20661424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycolysis, Glutaminolysis, and Fatty Acid Synthesis Are Required for Distinct Stages of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.
    Sanchez EL; Pulliam TH; Dimaio TA; Thalhofer AB; Delgado T; Lagunoff M
    J Virol; 2017 May; 91(10):. PubMed ID: 28275189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Virus-Like Vesicles of Kaposi's Sarcoma-Associated Herpesvirus Activate Lytic Replication by Triggering Differentiation Signaling.
    Gong D; Dai X; Xiao Y; Du Y; Chapa TJ; Johnson JR; Li X; Krogan NJ; Deng H; Wu TT; Sun R
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28515293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of direct transcriptional targets of the Kaposi's sarcoma-associated herpesvirus Rta lytic switch protein by conditional nuclear localization.
    Bu W; Palmeri D; Krishnan R; Marin R; Aris VM; Soteropoulos P; Lukac DM
    J Virol; 2008 Nov; 82(21):10709-23. PubMed ID: 18715905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. KSHV PAN RNA associates with demethylases UTX and JMJD3 to activate lytic replication through a physical interaction with the virus genome.
    Rossetto CC; Pari G
    PLoS Pathog; 2012; 8(5):e1002680. PubMed ID: 22589717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic factor siRNA screen during primary KSHV infection identifies novel host restriction factors for the lytic cycle of KSHV.
    Naik NG; Nguyen TH; Roberts L; Fischer LT; Glickman K; Golas G; Papp B; Toth Z
    PLoS Pathog; 2020 Jan; 16(1):e1008268. PubMed ID: 31923286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways.
    Xie J; Ajibade AO; Ye F; Kuhne K; Gao SJ
    Virology; 2008 Feb; 371(1):139-54. PubMed ID: 17964626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kaposi's sarcoma-associated herpesvirus RTA activates the processivity factor ORF59 through interaction with RBP-Jkappa and a cis-acting RTA responsive element.
    Liu Y; Cao Y; Liang D; Gao Y; Xia T; Robertson ES; Lan K
    Virology; 2008 Oct; 380(2):264-75. PubMed ID: 18786687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency.
    Lan K; Murakami M; Choudhuri T; Kuppers DA; Robertson ES
    Virology; 2006 Aug; 351(2):393-403. PubMed ID: 16701788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Major Histocompatibility Complex Class II HLA-DRĪ± Is Downregulated by Kaposi's Sarcoma-Associated Herpesvirus-Encoded Lytic Transactivator RTA and MARCH8.
    Sun Z; Jha HC; Pei YG; Robertson ES
    J Virol; 2016 Sep; 90(18):8047-58. PubMed ID: 27356905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early activation of the Kaposi's sarcoma-associated herpesvirus RTA, RAP, and MTA promoters by the tetradecanoyl phorbol acetate-induced AP1 pathway.
    Wang SE; Wu FY; Chen H; Shamay M; Zheng Q; Hayward GS
    J Virol; 2004 Apr; 78(8):4248-67. PubMed ID: 15047839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BET-Inhibitors Disrupt Rad21-Dependent Conformational Control of KSHV Latency.
    Chen HS; De Leo A; Wang Z; Kerekovic A; Hills R; Lieberman PM
    PLoS Pathog; 2017 Jan; 13(1):e1006100. PubMed ID: 28107481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and characterization of a new Kaposi's sarcoma-associated herpesvirus replication and transcription activator (RTA)-responsive element involved in RTA-mediated transactivation.
    Wen HJ; Minhas V; Wood C
    J Gen Virol; 2009 Apr; 90(Pt 4):944-953. PubMed ID: 19223488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency.
    Lan K; Kuppers DA; Verma SC; Sharma N; Murakami M; Robertson ES
    J Virol; 2005 Jun; 79(12):7453-65. PubMed ID: 15919901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kaposi's sarcoma-associated herpesvirus transactivator RTA promotes degradation of the repressors to regulate viral lytic replication.
    Yang Z; Yan Z; Wood C
    J Virol; 2008 Apr; 82(7):3590-603. PubMed ID: 18216089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kaposi's sarcoma-associated herpesvirus RTA promotes degradation of the Hey1 repressor protein through the ubiquitin proteasome pathway.
    Gould F; Harrison SM; Hewitt EW; Whitehouse A
    J Virol; 2009 Jul; 83(13):6727-38. PubMed ID: 19369342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.